Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)
United Arab Emirates flag United Arab Emirates · Delayed Price · Currency is AED
1.060
+0.010 (0.95%)
At close: May 22, 2026

ADX:JULPHAR Income Statement

Millions AED. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,0671,076992.21,2781,6161,143
Revenue Growth (YoY)
13.84%8.39%-22.33%-20.95%41.37%99.51%
Cost of Revenue
619.9639.6585.1852.41,058759.8
Gross Profit
447.1435.9407.1425.1557.9383.4
Selling, General & Admin
351.8357.8346.9458.3596.3451.9
Research & Development
2728.224.5---
Other Operating Expenses
-4.7-4.3-10.3-8.7-9.8-110
Operating Expenses
374.1381.7361.1449.6586.5341.9
Operating Income
7354.246-24.5-28.641.5
Interest Expense
-16.7-28.3-59.8-56.3-40.1-23.7
Interest & Investment Income
67.62.663.62.4
Earnings From Equity Investments
------31.4
Currency Exchange Gain (Loss)
0.10.10.7-0.2-
EBT Excluding Unusual Items
62.433.6-10.5-74.8-64.9-11.2
Gain (Loss) on Sale of Investments
4.44.43.33.52-5.5
Asset Writedown
-0.9-0.9-1.5---
Other Unusual Items
10.310.32.11.529.559.3
Pretax Income
76.247.4-6.6-69.8-33.442.6
Income Tax Expense
5.43.52.76.12.81.1
Earnings From Continuing Operations
70.843.9-9.3-75.9-36.241.5
Earnings From Discontinued Operations
11.8129.454.2-22.64.517.9
Net Income to Company
82.6173.344.9-98.5-31.759.4
Minority Interest in Earnings
-1.2-1.1-0.3-0.62.35
Net Income
81.4172.244.6-99.1-29.464.4
Net Income to Common
81.4172.244.6-99.1-29.464.4
Net Income Growth
-51.69%286.10%----
Shares Outstanding (Basic)
1,1551,1551,1551,1551,1551,155
Shares Outstanding (Diluted)
1,1551,1551,1551,1551,1551,155
Shares Change (YoY)
-----9.21%
EPS (Basic)
0.070.150.04-0.09-0.030.06
EPS (Diluted)
0.070.150.04-0.09-0.030.06
EPS Growth
-51.69%286.11%----
Free Cash Flow
95.785.2146.371.5-44.41.8
Free Cash Flow Per Share
0.080.070.130.06-0.040.00
Gross Margin
41.90%40.53%41.03%33.28%34.52%33.54%
Operating Margin
6.84%5.04%4.64%-1.92%-1.77%3.63%
Profit Margin
7.63%16.01%4.50%-7.76%-1.82%5.63%
Free Cash Flow Margin
8.97%7.92%14.74%5.60%-2.75%0.16%
EBITDA
115.598.2138.274.966.5128.5
EBITDA Margin
10.82%9.13%13.93%5.86%4.12%11.24%
D&A For EBITDA
42.54492.299.495.187
EBIT
7354.246-24.5-28.641.5
EBIT Margin
6.84%5.04%4.64%-1.92%-1.77%3.63%
Effective Tax Rate
7.09%7.38%---2.58%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.